BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31637221)

  • 1.
    Rugwizangoga B; Andersson ME; Kabayiza JC; Nilsson MS; Ármannsdóttir B; Aurelius J; Nilsson S; Hellstrand K; Lindh M; Martner A
    Front Cell Infect Microbiol; 2019; 9():340. PubMed ID: 31637221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphism rs368234815 of interferon lambda 4 gene and spontaneous clearance of hepatitis C virus in haemodialysis patients: a case-control study.
    Grzegorzewska AE; Mostowska A; Świderska MK; Marcinkowski W; Stolarek I; Figlerowicz M; Jagodziński PP
    BMC Infect Dis; 2021 Jan; 21(1):102. PubMed ID: 33482747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of functional variants in IFNL4 and IFNL3 for association with HCV clearance.
    O'Brien TR; Pfeiffer RM; Paquin A; Lang Kuhs KA; Chen S; Bonkovsky HL; Edlin BR; Howell CD; Kirk GD; Kuniholm MH; Morgan TR; Strickler HD; Thomas DL; Prokunina-Olsson L
    J Hepatol; 2015 Nov; 63(5):1103-10. PubMed ID: 26186989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-λ4 genetic variants influence clinical malaria episodes in a cohort of Kenyan children.
    Samayoa-Reyes G; Jackson C; Ogolla S; Sabourin K; Obajemu A; Dent AE; Prokunina-Olsson L; Rochford R
    Malar J; 2021 Apr; 20(1):196. PubMed ID: 33882912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Confounding by Single Nucleotide Polymorphism rs117648444 (P70S) Affects the Association of Interferon Lambda Locus Variants with Response to Interferon-α-Ribavirin Therapy in Patients with Chronic Genotype 3 Hepatitis C Virus Infection.
    Bhushan A; Ghosh S; Bhattacharjee S; Chinnaswamy S
    J Interferon Cytokine Res; 2017 Aug; 37(8):369-382. PubMed ID: 28727946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFNL4 rs368234815 and rs117648444 variants predict off-treatment HBsAg seroclearance in IFN-treated HBeAg-negative chronic hepatitis B patients.
    Galmozzi E; Facchetti F; Grossi G; Loglio A; Viganò M; Lunghi G; Colombo M; Lampertico P
    Liver Int; 2018 Mar; 38(3):417-423. PubMed ID: 28732143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of interferon lambda 4 rs368234815 as a predictor factor in treated patients with chronic hepatitis C genotype 1a infection.
    Jalilian S; Latifi SM; Makvandi M; Teimoori A; Azaran A; Parsanahad M; Kayedani G
    Indian J Med Microbiol; 2017; 35(2):262-268. PubMed ID: 28681817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic Interferon-λ3 (IFNL3) Gene Expression Reveals Not to Be Attenuated in Non-Favorable IFNL3 rs4803217 or IFNL4 rs368234815 Minor Allele Carriers in Chronic Hepatitis C.
    Amanzada A; Reinhardt L; Fey D; Zeisberg EM; Mihm S
    PLoS One; 2015; 10(11):e0143783. PubMed ID: 26606750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paraoxonase 1 gene (PON1) variants concerning hepatitis C virus (HCV) spontaneous clearance in hemodialysis individuals: a case-control study.
    Grzegorzewska AE; Mostowska A; Warchoł W; Jagodziński PP
    BMC Infect Dis; 2021 Aug; 21(1):875. PubMed ID: 34445971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms of interferon-λ4 and IL28B - effects on treatment response to interferon/ribavirin in patients with chronic hepatitis C.
    Stättermayer AF; Strassl R; Maieron A; Rutter K; Stauber R; Strasser M; Beinhardt S; Datz C; Scherzer TM; Steindl-Munda P; Gschwantler M; Trauner M; Hofer H; Ferenci P
    Aliment Pharmacol Ther; 2014 Jan; 39(1):104-11. PubMed ID: 24205831
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Baker FS; Wang J; Florez-Vargas O; Brand NR; Ogwang MD; Kerchan P; Reynolds SJ; Tenge CN; Were PA; Kuremu RT; Wekesa WN; Masalu N; Kawira E; Kinyera T; Otim I; Legason ID; Nabalende H; Chagaluka G; Mutalima N; Borgstein E; Liomba GN; Kamiza S; Mkandawire N; Mitambo C; Molyneux EM; Newton R; Prokunina-Olsson L; Mbulaiteye SM
    J Interferon Cytokine Res; 2023 Sep; 43(9):394-402. PubMed ID: 37366802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance and Value of IFN-Lambda3 and IFN-Lambda4 Genotyping in Patients with Chronic Hepatitis C (CHC) Genotype 2/3 in a Real World Setting.
    Wiegand SB; Heidrich B; Susser S; Rogalska-Taranta M; Petersen J; Böker KH; Grigorian N; Link R; Naumann U; John C; Lueth S; Malfertheiner P; Manns MP; Wedemeyer H; Sarrazin C; Cornberg M
    PLoS One; 2015; 10(12):e0145622. PubMed ID: 26699619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFNL4: Notable variants and associated phenotypes
    Fang MZ; Jackson SS; O'Brien TR
    Gene; 2020 Mar; 730():144289. PubMed ID: 31846709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-λ4 is a cell-autonomous type III interferon associated with pre-treatment hepatitis C virus burden.
    Lu YF; Goldstein DB; Urban TJ; Bradrick SS
    Virology; 2015 Feb; 476():334-340. PubMed ID: 25577150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon lambda 4 genotypes and resistance-associated variants in patients infected with hepatitis C virus genotypes 1 and 3.
    Peiffer KH; Sommer L; Susser S; Vermehren J; Herrmann E; Döring M; Dietz J; Perner D; Berkowski C; Zeuzem S; Sarrazin C
    Hepatology; 2016 Jan; 63(1):63-73. PubMed ID: 26406534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFNL4 and IFNL3 associated polymorphisms strongly influence the spontaneous IFN-alpha receptor-1 expression in HCV-infected patients.
    Bordi L; Caglioti C; Garbuglia AR; Lapa D; Castilletti C; Taibi C; Capobianchi MR; Lalle E
    PLoS One; 2015; 10(2):e0117397. PubMed ID: 25675103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon Lambda 4 Genotype Is Not Associated with Recurrence of Oral or Genital Herpes.
    Lang Kuhs KA; Kuniholm MH; Pfeiffer RM; Chen S; Desai S; Edlin BR; Peters MG; Plankey M; Sharp GB; Strickler HD; Villacres MC; Quinn TC; Gange SJ; Prokunina-Olsson L; Greenblatt RM; O'Brien TR
    PLoS One; 2015; 10(10):e0138827. PubMed ID: 26431156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon lambda 4 (IFNL4) gene polymorphism is associated with spontaneous clearance of HCV in HIV-1 positive patients.
    Alves CF; Grott CS; Lunge VR; Béria JU; Tietzmann DC; Stein AT; Simon D
    Genet Mol Biol; 2016; 39(3):374-9. PubMed ID: 27560987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of genetic variation in IL28B, IFNL4 and HLA genes on treatment responses against chronic hepatitis C virus infection.
    Sakhaee F; Ghazanfari M; Vaziri F; Jamnani FR; Davari M; Gharibzadeh S; Fateh R; Abdolrahimi F; Dizaji SP; Fateh A; Siadat SD
    Infect Genet Evol; 2017 Oct; 54():330-337. PubMed ID: 28739427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon lambda polymorphisms associate with body iron indices and hepatic expression of interferon-responsive long non-coding RNA in chronic hepatitis C.
    Wróblewska A; Bernat A; Woziwodzka A; Markiewicz J; Romanowski T; Bielawski KP; Smiatacz T; Sikorska K
    Clin Exp Med; 2017 May; 17(2):225-232. PubMed ID: 27125837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.